Projects funded by the NCN
Concept of the universal antibody targeting tumor cells resistant to first-line immunotherapeutics.
2019/35/B/NZ6/02450
Keywords:
complement system antibodies tumor cells
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ5_7: Human disease treatment
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: OPUS 18 - announced on 2019-09-16
Amount awarded: 1 704 000 PLN
Project start date (Y-m-d): 2020-07-28
Project end date (Y-m-d): 2024-07-27
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.